2019 American Transplant Congress
Clinical Presentation After Hepatitis B Recurrence In Liver Transplant Patients
Chang-Gung Hospital, Taoyuan, Taiwan
*Purpose: Combination of anti-hepatitis B immunoglobulin and antiviral agents is the standard care for prophylaxis of hepatitis B virus (HBV) recurrence after liver transplantation. However,…2019 American Transplant Congress
What Are You Smoking? The Impact of Donor Drug Use on Long Term Survival Post-Transplant
*Purpose: Drug use is a common aspect in the history of heart transplant donors. Whether prior or current drug use is associated with inferior post…2019 American Transplant Congress
Effect of Chronic Kidney Disease on Allo-Immune Response in Mice
*Purpose: Accumulation of memory T cells bearing markers of sustained antigen stimulation have been described in patients with chronic kidney disease (CKD). However, mouse models…2019 American Transplant Congress
Influence Of HLA-DR Mismatches On Long Term Outcomes Following Heart Transplantation
Division of Cardiology/ JC Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX
*Purpose: In the field of kidney transplantation, there is strong support for the beneficial effect of minimizing donor-recipient HLA incompatibility, and HLA-DR matching in particular…2019 American Transplant Congress
Cardiac Risk Assessment in Kidney Transplant Candidates: Clinical Usefulness of Different Guidelines
*Purpose: Despite cardiovascular (CV) assessment recommended all kidney transplant recipients to minimize perioperative risk, the utility and reliability of various assessments are not well established.…2019 American Transplant Congress
Patterns of Emergency Department (ED) Utilization between Transplant and Non-Transplant Centers and Impact on Clinical Outcomes in Kidney Recipients
*Purpose: There is a high rate of ED utilization in kidney recipients post-transplant (txp); ED visits are associated with readmission rates and lower 3-yr survival…2019 American Transplant Congress
The More You Wait, the More You Lose: Prostatectomy and Kidney Transplant Waiting Time in End Stage Renal Disease
1University Hospitals of Cleveland, Cleveland, OH, 2Case Western Researve University, Cleveland, OH
*Purpose: Optimal treatment and waiting time for patients with prostate cancer awaiting kidney transplant is unclear.*Methods: We studied male patients, 40 years or older, with…2019 American Transplant Congress
Kidney Grafts From Donors After Circulatory Death Provide Comparable Outcome To Donors After Brain Death Without Intracorporeal In Situ Cooling
Sapporo City General Hospital, Sapporo, Hokkaido, Japan
*Purpose: Donation after circulatory death (DCD) had been one and only source of deceased kidney donor in our country. The number of donation after brand…2019 American Transplant Congress
Cardioprotective Effects of Pre-Operative Cyclosporine in Patients Undergoing Heart Transplantation
Duke University Hospital, Durham, NC
*Purpose: The purpose of this study is to determine if pre-operative cyclosporine (Cya) decreases the rate of primary graft dysfunction (PGD) in patients undergoing orthotopic…2019 American Transplant Congress
Differences in Graft Survival for Pediatric and Adult Kidney Recipients Followed and Lost to Follow-Up
*Purpose: While the majority of kidney transplant recipients are followed by their program, many end up reported to the OPTN as lost to follow-up (LTFU).…
- « Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 66
- Next Page »